| Mrs Sarah Katherine Gandy, FNP-C | |
|
7777 Hennessy Blvd Ste 1000, Baton Rouge, LA 70808-4370 | |
| (225) 767-3900 | |
| (225) 766-2226 |
| Full Name | Mrs Sarah Katherine Gandy |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 7777 Hennessy Blvd Ste 1000, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144959123 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | RN143798 (Louisiana) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 225938 (Louisiana) | Primary |
| Entity Name | Our Lady Of The Lake Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033494943 PECOS PAC ID: 4587849781 Enrollment ID: O20120529000377 |
News Archive
People with high levels of antibodies to bacteria linked to periodontal disease have an increased risk for pancreatic cancer, while the risk is reduced in those with increased antibodies to oral commensal bacteria, say researchers.
Your skin tone and the amount of sunshine you receive-in addition to what foods you eat-all can influence the amount of vitamin D that your body has on hand for optimum health. In a preliminary and apparently first-of-its-kind study, Agricultural Research Service research physiologist Charles B. Stephensen and colleagues have developed a preliminary model that predicts an individual's vitamin D requirements.
National Institutes of Health (NIH) scientists have identified a promising lead for developing a new type of drug to treat infection caused by Staphylococcus aureus, a bacterium that frequently resists traditional antibiotics.
ast week's burst of world disorder was ideal for a news dump, and the White House didn't disappoint: On no legal basis, all 4.5 million residents of the five U.S. territories were quietly released from ObamaCare.
The New York Times: "GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated baby ointment and an ineffective antidepressant — the latest in a growing number of whistle-blower lawsuits that drug makers have settled with multimillion-dollar fines." The 20 medicines that were produced with "questionable safety" measures included "Avandia, a troubled diabetes drug; Coreg, a heart drug; and Tagamet an acid reflux drug."
› Verified 7 days ago
| Entity Name | Baton Rouge General Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609134766 PECOS PAC ID: 5193623643 Enrollment ID: O20120621000448 |
News Archive
People with high levels of antibodies to bacteria linked to periodontal disease have an increased risk for pancreatic cancer, while the risk is reduced in those with increased antibodies to oral commensal bacteria, say researchers.
Your skin tone and the amount of sunshine you receive-in addition to what foods you eat-all can influence the amount of vitamin D that your body has on hand for optimum health. In a preliminary and apparently first-of-its-kind study, Agricultural Research Service research physiologist Charles B. Stephensen and colleagues have developed a preliminary model that predicts an individual's vitamin D requirements.
National Institutes of Health (NIH) scientists have identified a promising lead for developing a new type of drug to treat infection caused by Staphylococcus aureus, a bacterium that frequently resists traditional antibiotics.
ast week's burst of world disorder was ideal for a news dump, and the White House didn't disappoint: On no legal basis, all 4.5 million residents of the five U.S. territories were quietly released from ObamaCare.
The New York Times: "GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated baby ointment and an ineffective antidepressant — the latest in a growing number of whistle-blower lawsuits that drug makers have settled with multimillion-dollar fines." The 20 medicines that were produced with "questionable safety" measures included "Avandia, a troubled diabetes drug; Coreg, a heart drug; and Tagamet an acid reflux drug."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sarah Katherine Gandy, FNP-C 5959 S Sherwood Forest Blvd, Baton Rouge, LA 70816-6038 Ph: (225) 767-3900 | Mrs Sarah Katherine Gandy, FNP-C 7777 Hennessy Blvd Ste 1000, Baton Rouge, LA 70808-4370 Ph: (225) 767-3900 |
News Archive
People with high levels of antibodies to bacteria linked to periodontal disease have an increased risk for pancreatic cancer, while the risk is reduced in those with increased antibodies to oral commensal bacteria, say researchers.
Your skin tone and the amount of sunshine you receive-in addition to what foods you eat-all can influence the amount of vitamin D that your body has on hand for optimum health. In a preliminary and apparently first-of-its-kind study, Agricultural Research Service research physiologist Charles B. Stephensen and colleagues have developed a preliminary model that predicts an individual's vitamin D requirements.
National Institutes of Health (NIH) scientists have identified a promising lead for developing a new type of drug to treat infection caused by Staphylococcus aureus, a bacterium that frequently resists traditional antibiotics.
ast week's burst of world disorder was ideal for a news dump, and the White House didn't disappoint: On no legal basis, all 4.5 million residents of the five U.S. territories were quietly released from ObamaCare.
The New York Times: "GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated baby ointment and an ineffective antidepressant — the latest in a growing number of whistle-blower lawsuits that drug makers have settled with multimillion-dollar fines." The 20 medicines that were produced with "questionable safety" measures included "Avandia, a troubled diabetes drug; Coreg, a heart drug; and Tagamet an acid reflux drug."
› Verified 7 days ago